Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1276 clinical trials
Featured trial
Chikungunya

The goal of this multi-center, randomized, double blind, placebo controlled study is to evaluate the safety and immunogenicity of PXVX0317 in healthy adult and adolescent subjects.

bilateral tubal ligation
hysterectomy
  • 0 views
  • 18 Apr, 2022
  • 1 location
Featured trial
Respiratory Syncytial Virus (RSV)

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of RSVpreF in the prevention of moderate to severe LRTI-RSV in adults.

  • 0 views
  • 18 Apr, 2022
  • 1 location
Featured trial
Respiratory Syncytial Virus (RSV)

The study will enroll up to 23000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …

vaccination
  • 0 views
  • 14 Jan, 2022
  • 1 location
Featured trial
PEDIATRIC VACCINES IN HEALTHY INFANTS AND TODDLERS (MENINGOCOCCAL CONJUGATE VACCINE)

MENINGOCOCCAL CONJUGATE VACCINE IS USED TO PREVENT INFECTION CAUSED BY MENINGOCOCCAL BACTERIA.  

conjugate vaccine
  • 10 views
  • 03 Oct, 2019
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People who have cancer tend to get sick more often. This is in part because of the cancer treatments they get. Because of this, they may get shingles. Scientists had thought people with chronic lymphocytic leukemia (CLL) should not get the shingles vaccine. Now there is a new shingles …

acalabrutinib
lymphoma
cancer
chronic lymphocytic leukemia
ibrutinib
  • 228 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Respiratory Syncytial Virus (RSV)

The study will enroll up to 23000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …

vaccination
  • 0 views
  • 21 Apr, 2022
  • 1 location
Featured trial
GSK Staph: Phase I, observer-blind, randomized, placebo-controlled study to assess safety, immunogenicity and efficacy of GSK S. aureus candidate vaccine when administered to healthy adults (dose-escalation) and to adults 18 to 50 years of age with a recent S. aureus skin and soft tissue infection (SSTI)

Safety, immunogenicity and efficacy of GSK S. aureus candidate vaccine (GSK3878858A) when administered to healthy adults (dose-escalation) and to adults 18 to 64 years of age with a recent S. aureus skin and soft tissue infection (SSTI). In the dose-escalation safety lead-in phase in healthy adults' safety and immunogenicity of …

  • 0 views
  • 18 May, 2022
  • 1 location
Featured trial
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

The primary objective of this study is:To evaluate the efficacy of fostamatinib when used in combination with standard of care (SOC) in subjects hospitalized with COVID-19 without respiratory failure and with certain high risk prognostic factors, as measured by the change in clinical status score.

covid-19
  • 2 views
  • 10 Dec, 2021
  • 35 locations
Featured trial
Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly with GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

The purpose of this study is to evaluate the immunogenicity, safety and tolerability of rMenB+OMV NZ and MenACWY vaccines when concomitantly administered to healthy subjects 16-18 years of age.

  • 0 views
  • 27 Jun, 2022
  • 1 location
Featured trial
A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older

A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older

  • 1672 views
  • 25 Mar, 2021
  • 1 location